Constitutive secretion of GM-CSF by three different cell lines derived from a single patient with a progressive cutaneous lymphoproliferative disorder

Cytokine

Volumn 8, Issue 4, 1996, Pages 323-329

  Marti, Rosa M ^a,b,d   Wasik, Mariusz A ^a,c   Kadin, Marshall E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Universitat de Lleida Facultat de Medicina Sabadell   (Spain)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

CD30; Cytokine; GM CSF; Lymphoma; Skin

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MESSENGER RNA;

ARTICLE; CELL GROWTH; CELL LINE; CELL SECRETION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MEGAKARYOBLAST; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0030007326     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0044     Document Type: Article

References (46)

1. Macon WR (1993) Cytokine expression in malignant lymphomas: A complicated puzzle with many pieces to assemble. Hum Pathol 24:1039.
2. Hsu S, Waldron JW, Hsu P, Hough AJ (1993) Cytokines in malignant lymphomas: Review and prospective evaluation. Hum Pathol 24:1040-1057.
3. Ford RJ, Tamayo A, Jun Li D, Cabanillas F (1993) Human B cell lymphomas: In vitro and in vivo studies on growth factors and cell growth. Leukemia and lymphoma 10:51-56.
4. Rook AH, Lessin SR (1993) The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sézary T cells. Arch Dermatol 129:486-489.
5. Foss FM, Koc Y, Stetler-Stevenson MA, Nguyen DT, O'Brien MC, Turner R, Sausville A (1994) Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2: potential autocrine or paracrine effectors in the Sézary syndrome. J Clin Oncol 12:326-335.
6. Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadlin ME (1992) Lymphomatoid papulosis, cutaneous T-cell lymphoma and Hodgkin's disease derived from a common T-cell clone. New Eng J Med 326:1115-1122.
7. Wasik MA, Seldin DC, Butmarc JR, Gertz R, Kadin ME (1993) Lack of IL-2 and IL-4 synthesis and partial loss of receptors for IL-2 and IL-4 in cell lines derived from different stages of an evolving T-cell lymphoproliferative disorder. Lab Invest 68:102A.
8. Merz H, Houssiau FA, Orscheschek K, Renauld JC, Fliedner A, Herin M, Noel H, Kadin M, Mueller-Hemerlink HK, Van Snick J, Feller AC (1991) Interleukin-9 expression in human malignant lymphomas: Unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood 78:1311-1317.
9. Avanzi GC, Brizzi MF, Giannotti J, Ciarletta A, Yang Y, Pegoraro L, Clark SC (1990) M-07e human leukemic factor dependent cell line provides a rapid and sensitive bioassay for the human cytokines GM-CSF and IL-3. J Cell Physiol 145:458-469.
10. Kuriu A, Ikeda H, Kanakura T, Griffin JD, Druker B, Yagura H, Kitamaya H, Ishiskawa J, Nishiura T, Kanayama Y, Yonezawa T, Tauri S (1991) Proliferation of human myeloid leukemia cell line associated with the tyrosine-phosphorylation and activation of the protoconcogene C-kit product. Blood 78:2834-2840.
11. Kadin ME, Cavaille-Coll MW, Sioutos N, Fletcher JA, Morton CC (1990) Childhool Ki-1+ anaplastic large cell lymphoma: Establishment and characterization of a new tumour cell line transplantable to SCID mice. Blood 76 (suppl 1):354a.
12. Su IJ, Lay ZD, Cheng YC (1994) Modulation of retinoic acid receptor alpha, growth factors and proto-oncogenes in retinoic acid-induced apoptosis of Ki-1 lymphoma cell line. Int J Oncol 4:1089-1095.
13. Tweeddale M, Jamal M, Nguyen A, Wang HX, Minden MD, Messner HA (1989) Production of growth factors by malignant lymphoma cell lines. Blood 74:572-578.
14. Schaadt M, Fonatsch C, Kirchner H, Diehl V (1979) Establishment of a malignant, Epstein-Barr-virus (EBV)-negative cell-line from the pleura effusion of a patient with Hodgkin's disease. Blut 38:185-190.
15. Drexler HG, Gaedicke G, Lok MS, Diehl V, Minowada J (1986) Hodgkin's disease derived cell lines HDLM-2 and L-428: Comparison of morphology, immunological and isoenzyme profiles. Leuk Res 10:487-500.
16. Kamesaki H, Fukuhara S, Tatsumi E, Uchino H, Yamabe H, Miwa H, Shirakawa S, Hatanaka M, Honjo T (1986) Cytochemical, immunologic, chromosomal and molecular genetic analysis of a novel cell line derived from Hodgkin's disease. Blood 68:285-292.
17. Wasik MA, Donnely RP, Beller DI (1988) Lymphokine-independent induction of macrophage membrane IL-1 expression by autoreactive T cells recognizing either class I or class II MHC determinants. J Immunol 141:3456-3462.
18. Wasik MA, Morimoto C (1990) Differential effects of cytokines on proliferative response of human CD4+ T cell subsets stimulated via CD3-TCR complex. J Immunol 144:3334-3338.
19. Kawasaki ES (1990) Amplification of RNA. In Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds) PCR protocols, a guide to methods and applications. Academic Press, Inc. San Diego, CA, pp 21-27.
20. Ehlers S, Smith KA (1991) Differentiation of T lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med 173:25-36.
21. Wasik M, Muirhead D, Rubocki R, Milgrom F (1986) Enzyme immunoassay with cell suspensions; studies on reactions between serum antibodies and cell-surface antigens. Int Archs Allergy Appl Immun 81:269-275.
22. Willemze R, Beljaards RC (1993) Spectrum of primary CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment. J Am Acad Dermatol 28:973-980.
23. Kadin ME (1990) The spectrum of Ki-1+ cutaneous lymphomas. Curr Probl Dermatol 19:132-143.
24. Drexler HG (1993) Recent results of the biology of Hodgkin and Reed-Sternberg cell lines. II. Continuous cell lines. Leuk-lymphoma 9:1-25.
25. Sieff CA (1987) Haematopoietic growth factors. J Clin Invest 79:1549-1556.
26. Clark SC, Kamen R (1987) The human hematopoietic colony-stimulating factors. Science 236:1229-1237.
27. Golde DW (1990) Overview of myeloid growth factors. Sem Hematol 27:1-7.
28. Tabbara IA, Robinson BE (1991) Hematopoietic growth factors. Anticancer Res 11:81-90.
29. Metcalf D (1991) Control of granulocytes and macrophages. Science 254:529-533.
30. Woods A, West J, Rasmussen R, Bottomly K (1987) Granulocyte-macrophage colony stimulating factor produced by cloned L3T4a+, Class II-restricted T cells induces HT-2 cells to proliferate. J Immunol 138:4293-4297.
31. Kupper T, Flood P, Coleman D, Horowitz M (1987) Growth of an interleukin 2/interleukin 4-dependent T cell line induced by granulocyte-macrophage colony-stimulating factor (GM-CSF). J Immunol 138:4288-4292.
32. Vowels BR, Cassin M, Vonderheid E, Rook AH (1992) Aberrant cytokine production by Sézary syndrome patients resembles murine Th2 cells. J Invest Dermatol 99:90-94.
33. Vowels BR, Lessin S, Cassin M, Rook AH (1992) Quantitative polymerase chain reaction analysis of interleukin 4 and interleukin 5 demonstrates aberrant cytokine production in Sézary syndrome. J Invest Dermatol 98:615.
34. Sachs L, Lotem J (1993) Control programmed cell death in normal and leukemic cells: new implications for therapy. Blood 82:15-21.
35. Morrissey PP, Bressler L, Park LS, Alpert A, Gillis S (1987) Granulocyte-macrophage colony-stimulating factor augments the primary antibody response by enhancing the function of antigen-presenting cells. J Immunol 139:1113-1119.
36. Markowicz S, Engleman EG (1990) Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro. J Clin Invest 85:955-961.
37. Kaplan G, Walsh G, Guido L, Meyn P, Burkhard RA, Abalos RM, Barker J, Frindt PA, Fajardo TT, Celona R, Cohn ZA (1992) Novel responses of human skin to intradermal recombinant granulocyte/marcrophage-colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth and enhanced wound healing. J Exp Med 175:1717-1728.
38. Kanakura Y, Sugahara H, Mitsui H, Ikeda H, Furitsu T, Yagura H, Kitamaya H, Konayama Y, Matsuzawa Y (1993) Functional expression of interleukin 2 receptor in a human factor dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor. Cancer Res 53:675-680.
39. Fermand J-P, Mitjavila M-T, Le Couedic J-P, Tsapis A, Berger R, Modigliani R, Seligmann M, Brouet J-C, Vainchenker W (1993) Role of granulocyte-macrophage colony-stimulating factor, interleukin-3 and interleukin-5 in the eosinophilia associated with T cell lymphoma. Br J Haematol 83:359-364.
40. Sawyers CL, Golde DW, Nimer QS (1992) Production of granulocyte colony-stimulating factor in two patients with lung cancer, leukocytosis and eosinophilia. Cancer 15:1342-1346.
41. Horn TD, Burke PJ, Karp JE, Hood AF (1991) Intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor causes a cutaneous eruption. Arch Dermatol 127:49-52.
42. Mehregan DR, Fransway AF, Edmenson JH, Leiferman KM (1992) Cutaneous reactions to granulocyte-macrophage colony stimulating factor. Arch Dermatol 128:1055-1059.
43. Sanderson CJ (1992) Interleukin-5, eosinophils and disease. Blood 79:3101-3109.
44. Cebon J, Layton J, Pavlovic R, Iaria J, Dyer W, Morstyn G (1991) Endogenous cytokine production in response to sepsis in neutropenic and non-neutropenic patients. Blood 78 (suppl 1):8a.
45. Rapoport AP, Abboud CN, DiPersioo JF (1992) Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF): Receptor biology, single transduction and neutrophil activation. Blood Rev 6:43-57.
46. Gasson JC, Weisbart RH, Kaufman SE, Clark SC, Hewick RM, Wong CG, Golde DW (1984) Purified human granulocyte-macrophage colony-stimulating factor: Direct action on neutrophils. Science 226:1339-1342.